INSIGHTS ON REGULATORY COMPLIANCE

• Guide To PUPSIT And Annex 1 In Aseptic Processing

  Pre-use, post-sterilization integrity testing (PUPSIT) ensures filters remain undamaged and effective during aseptic manufacturing. Discover how you can successfully perform PUPSIT with proven solutions.

• Elevating Environmental Monitoring Trending: From Data To Insight

  Move beyond raw data by using heat maps and site-specific limits to identify contamination hotspots. Transform your environmental monitoring into a proactive strategy for operational excellence.

• After Go-Live: A GMP Playbook For Vendor Partnership

  After go-live, system risk increases. Examine how ongoing validation, controlled change, and reliable issue resolution determine whether a system stays compliant or becomes a liability.

• Understanding The Regulatory Landscape For Ophthalmic Drug Products

  Learn how evolving ophthalmic regulations, contamination control strategies, and advanced packaging solutions can help support compliance, product quality, and patient safety.

• Aiming For Success In Early mAb Process Development And Beyond

  7/15/2025

  Developing a monoclonal antibody (mAb) requires strict quality compliance. Building on a strong foundation from the start with a quality by design (QbD) approach is key for success and minimizing variability.

• Accelerated Tox Offerings: A Recipe For Streamlining IND Applications

  4/22/2025

  Accelerating the timeline to tox material can significantly enhance the drug development process, enabling faster IND submissions and providing crucial time savings for toxicology studies.

• Strategic Supply Chain Leadership: Driving Biopharma Growth

  4/22/2026

  Amid a volatile pharma supply chain, strategic sourcing is now critical. Prioritizing your raw material supply ensures operational continuity, consistent performance, compliance, and on-time delivery.

• Integrating Phase-Appropriate Quality Standards

  12/9/2024

  Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.

• The CMC Regulatory Landscape During Product Development, Manufacturing

  7/11/2025

  Through case studies and practical insights spanning complex drug substance and drug products like ADCs, learn more about navigating complexities with integrated regulatory services and strategic guidance.